Novel mouse model for gardner syndrome generated by a large-scale N-ethyl-N-nitrosourea mutagenesis program

Cancer Science

Volumn 104, Issue 7, 2013, Pages 937-944

  Toki, Hideaki ^a   Inoue, Maki ^a   Motegi, Hiromi ^a   Minowa, Osamu ^a   Kanda, Hiroaki ^b   Yamamoto, Noriko ^b   Ikeda, Ami ^a   Karashima, Yuko ^a   Matsui, Junko ^a   Kaneda, Hideki ^a   Miura, Ikuo ^a   Suzuki, Tomohiro ^a   Wakana, Shigeharu ^a   Masuya, Hiroshi ^a   Gondo, Yoichi ^a   Shiroishi, Toshihiko ^c   Akiyama, Tetsu ^d   Yao, Ryoji ^b   Noda, Tetsuo ^a,b  

^a RIKEN   (Japan)

^b CANCER INSTITUTE   (Japan)

^c NATIONAL INSTITUTE OF GENETICS   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYLNITROSOUREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; COLON POLYPOSIS; DOMINANT INHERITANCE; FEMALE; GARDNER SYNDROME; GENE SEQUENCE; IMMUNOBLOTTING; INTESTINE TUMOR; MALE; MOUSE; MUTAGENESIS; NONHUMAN; OSTEOMA; POINT MUTATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; CODON; DISEASE MODELS, ANIMAL; ETHYLNITROSOUREA; FEMALE; GARDNER SYNDROME; GENES, APC; GENOME; HETEROZYGOTE; INTESTINAL NEOPLASMS; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MUTAGENESIS; MUTAGENS; MUTATION; OSTEOMA; PHENOTYPE;

EID: 84880729190     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12161     Document Type: Article

References (29)

1. Hitotsumachi S, Carpenter DA, Russell WL. Dose-repetition increases the mutagenic effectiveness of N-ethyl-N-nitrosourea in mouse spermatogonia. Proc Natl Acad Sci U S A 1985; 82: 6619-21.
2. Noveroske JK, Weber JS, Justice MJ. The mutagenic action of N-ethyl-N-nitrosourea in the mouse. Mamm Genome 2000; 11: 478-83.
3. Justice MJ, Noveroske JK, Weber JS, Zheng B, Bradley A. Mouse ENU mutagenesis. Hum Mol Genet 1999; 8: 1955-63.
4. Nolan PM, Peters J, Strivens M et al. A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nat Genet 2000; 25: 440-3.
5. Hrabe de Angelis MH, Flaswinkel H, Fuchs H et al. Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat Genet 2000; 25: 444-7.
6. Inoue M, Sakuraba Y, Motegi H et al. A series of maturity onset diabetes of the young, type 2 (MODY2) mouse models generated by a large-scale ENU mutagenesis program. Hum Mol Genet 2004; 13: 1147-57.
7. Groden J, Thliveris A, Samowitz W et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66: 589-600.
8. Nishisho I, Nakamura Y, Miyoshi Y et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991; 253: 665-9.
9. Taketo MM, Edelmann W. Mouse models of colon cancer. Gastrienterology 2009; 136: 780-98.
10. McCart AE, Vickaryous NK, Silver A. Apc mice: models, modifiers and mutants. Pathol Res Pract 2008; 204: 479-90.
11. Gardner EJ. A genetic and clinical study of intestinal polyposis, a predisposing factor for carcinoma of the colon and rectum. Am J Hum Genet 1951; 3: 167-76.
12. Hinoi T, Akyol A, Theisen BK et al. Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation. Cancer Res 2007; 67: 9721-30.
13. Dikovskaya D, Schiffmann D, Newton IP et al. Loss of APC induces polyploidy as a result of a combination of defects in mitosis and apoptosis. J Cell Biol 2007; 176: 183-95.
14. Aoki K, Taketo M. Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene. J Cell Sci 2007; 120: 3327-35.
15. Sasai H, Masaki M, Wakitani K. Adenomatous polyposis coli (APC) is required for normal development of skin and thymus. Carcinogenesis 2000; 21: 953-8.
16. Shibata H, Toyama K, Shioya H et al. Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science 1997; 278: 120-3.
17. Kuraguchi M, Wang XP, Bronson RT et al. Adenomatous polyposis coli (APC) is required for normal development of skin and thymus. PLoS Genet 2006; 2: 1362-74.
18. Colnot S, Niwa-Kawakita M, Hamard G et al. Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers. Lab Invest 2004; 84: 1619-30.
19. Robanus-Maandag EC, Koelink PJ, Breukel C et al. A new conditional Apc-mutant mouse model for colorectal cancer. Carcinogenesis 2010; 31: 946-52.
20. Oshima M, Oshima H, Kitagawa K, Kobayashi M, Itakura C, Taketo M. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Ape gene. Proc Natl Acad Sci U S A. 1995; 92: 4482-6.
21. Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990; 247: 322-4.
22. Ito M, Miura S, Noda T. Mouse model for familial adenomatous polyposis coli and APC gene. Protein, Nucleic acid and Enzyme 1995; 40: 2035-44. (Japanese.)
23. Gaspar C, Franken P, Molenaar L et al. A targeted constitutive mutation in the Apc tumor suppressor gene underlies mammary but not intestinal tumorigenesis. PLoS Genet 2009; 5: 1-13.
24. Smits R, Kielman MF, Breukel C et al. Apc1638T: a mouse model delineating critical domains of the adenomatous polyposis coli protein involved in tumorigenesis and development. Genes Dev 1999; 13: 1309-21.
25. Douglas DS, Moran JL, Bermingham JR Jr et al. Concurrent Lpin1 and Nrcam mouse mutations result in severe peripheral neuropathy with transitory hindlimb paralysis. J Neurosci 2009; 29: 12089-100.
26. Half E, Bercovich D, Rozen P. Familial adenomatous polyposis. Orphanet J Rare Dis 2009; 4: 22-45.
27. Enomoto M, Konishi M, Iwama T et al. The relationship between frequencies of extracolonic manifestations and the position of APC germline mutation in patients with familial adenomatous polyposis. Jpn J Clin Oncol 2000; 30: 82-8.
28. Bisgaard ML, Bülow S. Familial adenomatous polyposis (FAP): genotype correlation to FAP phenotype with osteomas and sebaceous cysts. Am J Med Genet 2006; 140: 200-4.
29. Dobbie Z, Spycher M, Mary JL et al. Correlation between the development of extracolonic manifestations in FAP patients and mutations beyond codon 1403 in the APC gene. J Med Genet 1996; 33: 274-80.